Jalaukaavacharana and Swarjikadi tail in Chronic Wound

A clinical evaluation of Jalaukaavacharana with Swarjikadi tail in the management of Dushta Vrana w.s.r to Chronic Wound - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/04/108534

Enrollment

Registered

2026-04-16

Start date

Unknown

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L984- Non-pressure chronic ulcer of skin, not elsewhere classified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients fit for Raktamokshana patient having with signs and symptoms of Dushta Vrana.

Exclusion criteria

Exclusion criteria: Patient associated with chronic wound with other disorders e.g. AIDS, H.I.V, hepatitis, Malignant ulcers, Tubercular ulcers, diabetic wound, Syphlitic ulcers, Leprosy, Martorels hypertensive ulcers and Patient having history of bleeding disorders.

Design outcomes

Primary

Measure	Time frame
Assessment will be carried out using appropriate statistical methods to ensure accuracy and reliability of results. The primary evaluation will be based on the degree of relief in the signs and symptoms of Dushta Vrana. In addition, findings from laboratory and radiological investigations will be considered. All observations will be systematically recorded using a specially designed research proforma and analyzed through a structured scoring pattern to assess overall therapeutic effectiveness.Timepoint: 60 days	—

Measure

Time frame

Assessment will be carried out using appropriate statistical methods to ensure accuracy and reliability of results. The primary evaluation will be based on the degree of relief in the signs and symptoms of Dushta Vrana. In addition, findings from laboratory and radiological investigations will be considered. All observations will be systematically recorded using a specially designed research proforma and analyzed through a structured scoring pattern to assess overall therapeutic effectiveness.Timepoint: 60 days

—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr Rakesh Raushan

Government Ayurvedic College and Hospital

dr.raushan.rakesh@gmail.com8630160228

Outcome results